www.inpharmation.comInpharmation is a world leader specializing in pharmaceutical pricing, market access, demand market research, forecast modeling, international reference pricing and launch sequence optimization. Inpharmation deploys evidence-based research techniques and builds cutting-edge evidence-based models and programs (both bespoke and off-the-shelf) to enable pharmaceutical executives to make major business decisions. All the top ten pharmaceutical companies (and many, many more) are customers.Founded in 1998, Inpharmation has grown year on year and has a truly international customer base. Inpharmation has taught over a thousand high-level pharmaceutical executives around the globe how to forecast and price pharmaceuticals. Gary Johnson, founder and Chairman, is a leading expert and author of a number of best-selling books on pharmaceutical pricing, market access, forecasting, market research and conjoint analysis. Gary's books have been finalists in the prestigious MCA Business Book Awards and semi-finalist for the Financial Times Global Business Book Awards. He gives lectures around the world and is a Sloan Fellow of London Business School and a Fellow of the Royal Society of Medicine.